MRFF 2026 BioMedTech Incubator
Department of Health, Disability and Ageing · Australia
The MRFF 2026 BioMedTech Incubator grant opportunity supports suitable organisations to identify, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects with commercial potential. It aims to help novel biomarkers, diagnostics, therapeutics, assistive devices and digital technologies progress through early R&D to become de-risked and attractive to private investment for commercialisation.
Funding
Up to $33M
Deadline
22 July 2026
Location
Australia
Who Can Apply
What's Funded
Expected Outcomes
Free Eligibility Check
Answer a few quick questions to find out if you qualify for this grant. Takes about 2 minutes.
Check EligibilityKey Information
Applicant Types
Stage
Funding Purposes
Keywords
Frequently Asked Questions
What is the MRFF 2026 BioMedTech Incubator?
The MRFF 2026 BioMedTech Incubator is a research grant offered by Department of Health, Disability and Ageing in Australia, providing Up to $33M in funding. The MRFF 2026 BioMedTech Incubator grant opportunity supports suitable organisations to identify, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects with commercial potential. It aims to help novel biomarkers, diagnostics, therapeutics, assistive devices and digital technologies progress through early R&D to become de-risked and attractive to private investment for commercialisation.
How much funding does the MRFF 2026 BioMedTech Incubator provide?
The MRFF 2026 BioMedTech Incubator provides Up to $33M in funding.
Who is eligible for the MRFF 2026 BioMedTech Incubator?
Must have an active ABN and be incorporated in Australia. Eligible lead applicants include medical research institutes, universities, corporate Commonwealth entities, and corporations including businesses and not-for-profits. Individuals, partnerships, unincorporated associations, trusts (unless via an incorporated trustee), and non-corporate Commonwealth entities are ineligible. Applicants and project partners must not be on the National Redress Scheme non-joined list, and employers with 100 or more employees must comply with the Workplace Gender Equality Act 2012.
When does the MRFF 2026 BioMedTech Incubator close?
Applications close on 22 July 2026.
What activities are funded?
Funded activities involve running incubator-style support programs that identify, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects with commercial potential, including projects involving biomarkers, diagnostics, therapeutics, assistive devices and digital technologies.
How do I apply for the MRFF 2026 BioMedTech Incubator?
Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.
Need help applying?
Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.